The chief medical and development officer of Kyverna Therapeutics went over new data the company presented at AANEM’s 2025 meeting.
Naji Gehchan, MD, MBA
Advertisement
The chief medical and development officer of Kyverna Therapeutics
Articles by Naji Gehchan, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
